Anti-interleukin 12/23 in the treatment of erythema nodosum and Crohn disease: A case report

Dermatol Ther. 2019 Mar;32(2):e12811. doi: 10.1111/dth.12811. Epub 2019 Jan 23.

Authors

Rocco Spagnuolo¹, Stefano Dastoli², Martina Silvestri², Cristina Cosco³, Pietro Garieri⁴, Luigi Bennardo², Steven Paul Nisticò²

Affiliations

¹ Department of Medical and Surgical Science, Magna Graecia University, Catanzaro, Italy.
² Department of Health Sciences, Unit of Dermatology, Magna Graecia University, Catanzaro, Italy.
³ Unit of Gastroenterology, AOU Mater Domini, Catanzaro, Italy.
⁴ Unit of Plastic Surgery, University of Milan, Milan, Italy.

PMID: 30620119
DOI: 10.1111/dth.12811

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Adult
Crohn Disease / drug therapy*
Crohn Disease / immunology
Erythema Nodosum / drug therapy*
Erythema Nodosum / immunology
Female
Humans
Interleukin-12 / antagonists & inhibitors
Interleukin-23 / antagonists & inhibitors
Ustekinumab / pharmacology
Ustekinumab / therapeutic use*

Substances

Interleukin-23
Interleukin-12
Ustekinumab